Dvant Pharmaceuticals Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.23M

  • Investors
  • 3

Dvant Pharmaceuticals General Information

Description

Operator of a pharmaceutical company developing drugs intended to treat cancer. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3646 Northbrook Drive
  • Ypsilanti, MI 48198
  • United States
+1 (734)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 3646 Northbrook Drive
  • Ypsilanti, MI 48198
  • United States
+1 (734)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dvant Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 13-Oct-2026 $1.23M Completed Stealth
2. Accelerator/Incubator Completed Stealth
1. Seed Round 19-Mar-2021 $1.2M $1.2M Completed Stealth
To view Dvant Pharmaceuticals’s complete valuation and funding history, request access »

Dvant Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Dvant Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Dvant Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dvant Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clarevia Ventures Venture Capital Minority
Transhuman Capital Venture Capital Minority
Innovation Partnerships Venture Capital Minority
To view Dvant Pharmaceuticals’s complete investors history, request access »

Dvant Pharmaceuticals FAQs

  • When was Dvant Pharmaceuticals founded?

    Dvant Pharmaceuticals was founded in 2021.

  • Where is Dvant Pharmaceuticals headquartered?

    Dvant Pharmaceuticals is headquartered in Ypsilanti, MI.

  • What is the size of Dvant Pharmaceuticals?

    Dvant Pharmaceuticals has 3 total employees.

  • What industry is Dvant Pharmaceuticals in?

    Dvant Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Dvant Pharmaceuticals a private or public company?

    Dvant Pharmaceuticals is a Private company.

  • What is the current valuation of Dvant Pharmaceuticals?

    The current valuation of Dvant Pharmaceuticals is .

  • What is Dvant Pharmaceuticals’s current revenue?

    The current revenue for Dvant Pharmaceuticals is .

  • How much funding has Dvant Pharmaceuticals raised over time?

    Dvant Pharmaceuticals has raised $2.43M.

  • Who are Dvant Pharmaceuticals’s investors?

    Clarevia Ventures, Transhuman Capital, and Innovation Partnerships have invested in Dvant Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process